Jasper Stevens

2.4k total citations
97 papers, 1.8k citations indexed

About

Jasper Stevens is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Jasper Stevens has authored 97 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Endocrinology, Diabetes and Metabolism, 22 papers in Molecular Biology and 16 papers in Surgery. Recurrent topics in Jasper Stevens's work include Diabetes Treatment and Management (11 papers), Epilepsy research and treatment (9 papers) and Receptor Mechanisms and Signaling (7 papers). Jasper Stevens is often cited by papers focused on Diabetes Treatment and Management (11 papers), Epilepsy research and treatment (9 papers) and Receptor Mechanisms and Signaling (7 papers). Jasper Stevens collaborates with scholars based in Netherlands, United States and United Kingdom. Jasper Stevens's co-authors include David Oscier, Terry J. Hamblin, G J Mufti, David Machin, Jacobus Burggraaf, Meindert Danhof, Elizabeth C. M. de Lange, Anneke C. Dijkmans, Cees van Nieuwkoop and Daan J. Touw and has published in prestigious journals such as Science, The Lancet and JAMA.

In The Last Decade

Jasper Stevens

90 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jasper Stevens Netherlands 19 549 323 318 235 233 97 1.8k
Stilla Frede Germany 30 309 0.6× 1.1k 3.3× 147 0.5× 106 0.5× 85 0.4× 80 3.0k
Hasan Özkan Türkiye 30 485 0.9× 439 1.4× 174 0.5× 75 0.3× 105 0.5× 132 2.6k
Davide Agnello Italy 21 1.3k 2.4× 636 2.0× 336 1.1× 164 0.7× 71 0.3× 26 3.1k
Hiroshi Yamasaki Japan 29 268 0.5× 634 2.0× 55 0.2× 254 1.1× 142 0.6× 155 3.2k
Christoph Baerwald Germany 27 201 0.4× 527 1.6× 69 0.2× 136 0.6× 169 0.7× 134 2.3k
Yohnosuke Kobayashi Japan 26 173 0.3× 535 1.7× 79 0.2× 150 0.6× 238 1.0× 135 2.4k
Katharina Kurz Austria 28 255 0.5× 502 1.6× 175 0.6× 81 0.3× 159 0.7× 78 2.1k
John T. Sullivan United States 24 293 0.5× 391 1.2× 74 0.2× 531 2.3× 151 0.6× 52 1.8k
Albert Wölfler Austria 29 498 0.9× 587 1.8× 209 0.7× 84 0.4× 24 0.1× 82 2.5k
Yuhei Hamasaki Japan 26 111 0.2× 489 1.5× 48 0.2× 313 1.3× 152 0.7× 120 2.2k

Countries citing papers authored by Jasper Stevens

Since Specialization
Citations

This map shows the geographic impact of Jasper Stevens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasper Stevens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasper Stevens more than expected).

Fields of papers citing papers by Jasper Stevens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasper Stevens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasper Stevens. The network helps show where Jasper Stevens may publish in the future.

Co-authorship network of co-authors of Jasper Stevens

This figure shows the co-authorship network connecting the top 25 collaborators of Jasper Stevens. A scholar is included among the top collaborators of Jasper Stevens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasper Stevens. Jasper Stevens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Veen, J.C.C.M. in ’t, Huib A.M. Kerstjens, Jasper Stevens, et al.. (2025). Hair analysis for monitoring adherence to inhaled respiratory medications: possibilities and limitations. European Journal of Clinical Pharmacology. 81(12). 1745–1758.
2.
3.
Sridhar, Vikas S., Yuliya Lytvyn, Yangqing Deng, et al.. (2025). Efficacy, Mechanisms, and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Kidney Transplant Recipients. Clinical Journal of the American Society of Nephrology.
4.
5.
6.
7.
8.
Gelder, Maaike K. van, et al.. (2021). Simplified Iohexol-Based Method for Measurement of Glomerular Filtration Rate in Goats and Pigs. Biology. 10(6). 461–461. 2 indexed citations
9.
Stevens, Jasper, et al.. (2021). A Review of the Dose Justification of Phase 3 Trials to Regulatory Authorities for Drugs Intended for the Treatment of Type 2 Diabetes in Europe. Frontiers in Pharmacology. 12. 626766–626766. 2 indexed citations
10.
Dekkers, Claire C. J., Sean J. Barbour, David W. Boulton, et al.. (2021). Evaluation of the Pharmacokinetics and Exposure–Response Relationship of Dapagliflozin in Patients without Diabetes and with Chronic Kidney Disease. Clinical Pharmacokinetics. 60(4). 517–525. 8 indexed citations
11.
Esdonk, Michiel J. van & Jasper Stevens. (2021). The power of modelling pulsatile profiles. Journal of Pharmacokinetics and Pharmacodynamics. 48(3). 439–444.
12.
Goulooze, Sebastiaan C., Annelieke C. Kruithof, Anirudh Gautam, et al.. (2020). The effect of food and formulation on the population pharmacokinetics of cholesteryl ester transferase protein inhibitor DRL‐17822 in healthy male volunteers. British Journal of Clinical Pharmacology. 86(10). 2095–2101. 1 indexed citations
13.
Kay, Denis G., et al.. (2016). First in human study with a prodrug of galantamine: Improved benefit‐risk ratio?. Alzheimer s & Dementia Translational Research & Clinical Interventions. 2(1). 13–22. 15 indexed citations
14.
Reijers, Joannes A. A., et al.. (2016). Use of population approach non-linear mixed effects models in the evaluation of biosimilarity of monoclonal antibodies. European Journal of Clinical Pharmacology. 72(11). 1343–1352. 4 indexed citations
15.
Lawrence, Jeffry B., Jacobus Burggraaf, Jonathan M. Ducore, et al.. (2016). A Phase Ib, Dose Escalation Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Recombinant Coagulation Factor VIIa in Congenital Hemophilia A or B. 22. 68–68. 1 indexed citations
16.
17.
Gowen, Brian B., Donald F. Smee, Jeffery O. Hall, et al.. (2008). T-705 Treatment of Late Stage Disease in an Arenaviral Hemorrhagic Fever Model:T-705 Efficacy and Reduced Toxicity Suggests a Viable Alternative to RibavirinTherapy. PLoS ONE. 3(11). 3725. 2 indexed citations
18.
Stevens, Jasper, Duane Denney, & Patricia Szot. (1996). Kindling with clozapine: behavioral and molecular consequences. Epilepsy Research. 26(1). 295–304. 20 indexed citations
19.
Oscier, David, et al.. (1990). Correlation of chromosome abnormalities with laboratory features and clinical course in B‐cell chronic lymphocytic leukaemia. British Journal of Haematology. 76(3). 352–358. 62 indexed citations
20.
Weinberger, D.R., Christian Kaufmann, Jasper Stevens, et al.. (1985). Abstract 34. Inoculation of schizophrenic brains to rodents and primates: behavioral and neuropathological observations. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 9(3). 307–307. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stilla Frede Breakdown of academic impact, for papers by Hasan Özkan Breakdown of academic impact, for papers by Davide Agnello Breakdown of academic impact, for papers by Hiroshi Yamasaki Breakdown of academic impact, for papers by Christoph Baerwald Breakdown of academic impact, for papers by Yohnosuke Kobayashi Breakdown of academic impact, for papers by Katharina Kurz Breakdown of academic impact, for papers by John T. Sullivan Breakdown of academic impact, for papers by Albert Wölfler Breakdown of academic impact, for papers by Yuhei Hamasaki
Rankless by CCL
2026